Markets:

Overview

News

Currencies

International

Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

102.11 +0.33 (+0.32%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Exact Sciences Corporation - Common Stock

< Previous 1 2 3 4 Next >

Halper Sadeh LLC Encourages EXAS, FRGE, TBHC, FFWM Shareholders to Contact the Firm to Discuss Their Rights

January 09, 2026

Shareholders should contact the firm as there may be limited time to enforce your rights.

From Halper Sadeh LLC

Via GlobeNewswire

Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS

December 11, 2025

From Exact Sciences Corp.

Via Business Wire

Halper Sadeh LLC Encourages SEE, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights

November 27, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

Exact Sciences Reinforces International Leadership in Breast Cancer with Strong Presence at 2025 San Antonio Breast Cancer Symposium

November 24, 2025

From Exact Sciences Corp.

Via Business Wire

Halper Sadeh LLC Encourages EXAS, NVRI, MRUS Shareholders to Contact the Firm to Discuss Their Rights

November 22, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights

From Halper Sadeh LLC

Via GlobeNewswire

Exact Sciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS

November 21, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Exact Sciences Corporation (Nasdaq – EXAS)

November 20, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

EXAS Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Exact Sciences Corporation is Fair to Shareholders

November 20, 2025

From Halper Sadeh LLC

Via Business Wire

Exact Sciences Announces Expiration of the HSR Waiting Period for Exclusive License to Freenome’s Blood-Based Colorectal Cancer Screening Tests

November 10, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences Announces Breakthrough Results from Landmark Study Demonstrating Superior Early Detection of Liver Cancer with Blood-Based Surveillance Test

November 07, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences to Participate in November Investor Conference

November 04, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences Announces Third Quarter 2025 Results

November 03, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences Presents New Findings at ACG 2025 Demonstrating How the Cologuard Test Helps Improve Adherence and Close Screening Gaps

October 27, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences Schedules Third Quarter 2025 Earnings Call

October 08, 2025

From Exact Sciences Corp.

Via Business Wire

New Study in Journal of the National Cancer Institute Finds Cologuard Plus™ Provides the Most Life-Years Gained with the Fewest Colonoscopies

October 07, 2025

From Exact Sciences Corp.

Via Business Wire

Horror Icon Matthew Lillard and Exact Sciences Help Adults 45+ Conquer Fear and Get Screened for Colon Cancer with the Cologuard® Test

September 22, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences Launches Cancerguard™, First-of-Its-Kind Multi-Cancer Early Detection Blood Test

September 10, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences to Participate in September Investor Conferences

August 19, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences Announces Second Quarter 2025 Results

August 06, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences Announces Exclusive License with Freenome for Blood-Based Colorectal Cancer Screening Tests

August 06, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard Plus™ Test

July 31, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences Schedules Second Quarter 2025 Earnings Call

July 14, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences Announces Medicare Coverage for Oncodetect™ Molecular Residual Disease Test in Colorectal Cancer

July 09, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences Announces Expanded Clinical Validation of the Oncodetect™ Test and Molecular Residual Disease Innovation Roadmap

May 28, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences to Participate in June Investor Conference

May 27, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025

May 22, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences Earns 2025 Great Place To Work® Certification™

May 12, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences to Participate in May Investor Conference

May 02, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences Announces First-Quarter 2025 Results

May 01, 2025

From Exact Sciences Corp.

Via Business Wire

Exact Sciences to Highlight Cologuard® Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025

April 29, 2025

From Exact Sciences Corp.

Via Business Wire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.